ArticleClinical drug investigation2020

A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.

Tae-Hwan Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.